Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(27 sites)
Croatia
Sobi Investigational Site, Zagreb Czechia
Sobi Investigational Site, Brno Sobi Investigational Site, Ostrava Sobi Investigational Site, Prague France
Sobi Investigational Site, Bordeaux Sobi Investigational Site, Marseille Sobi Investigational Site, Montpellier Sobi Investigational Site, Nantes Sobi Investigational Site, Paris Sobi Investigational Site, Rennes Sobi Investigational Site, Rouen Germany
Sobi Investigational Site, Berlin Sobi Investigational Site, Bonn Sobi Investigational Site, Frankfurt am Main Sobi Investigational Site, Hamburg Sobi Investigational Site, Munich Ireland
Sobi Investigational Site, Dublin Italy
Sobi Investigational Site, Turin Spain
Sobi Investigational Site, A Coruña Sobi Investigational Site, Barcelona Sobi Investigational Site, Málaga Sobi Investigational Site, Palma de Mallorca Sobi Investigational Site, Zaragoza United Kingdom
Sobi Investigational Site, Birmingham Sobi Investigational Site, Cardiff Sobi Investigational Site, London Sobi Investigational Site, Manchester